u 74389f has been researched along with thromboxane b2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corson, JD; Hoballah, JJ; Kresowik, TF; Mohan, CR; Sharp, WJ | 1 |
| Garrison, RN; Krysztopik, RJ; Matheson, PJ; Spain, DA; Wilson, MA | 1 |
2 other study(ies) available for u 74389f and thromboxane b2
| Article | Year |
|---|---|
Lazaroid U74389G attenuates skeletal muscle reperfusion injury in a canine model.
Topics: Analysis of Variance; Animals; Antioxidants; Dogs; Edema; In Vitro Techniques; Ischemia; Muscle, Skeletal; Necrosis; Peroxidase; Pregnatrienes; Reperfusion; Reperfusion Injury; Steroids, Heterocyclic; Thromboxane B2; Time Factors | 1995 |
Lazaroid and pentoxifylline suppress sepsis-induced increases in renal vascular resistance via altered arachidonic acid metabolism.
Topics: Animals; Antioxidants; Arachidonic Acid; Bacteremia; Kidney; Male; Pentoxifylline; Phosphodiesterase Inhibitors; Pregnatrienes; Rats; Rats, Wistar; Thromboxane A2; Thromboxane B2; Vascular Resistance | 2000 |